BioStem Technologies Announces Its CEO And COO Each Exercised A Portion Of Their Outstanding Options To Purchase 250K Shares At An Exercise Price Of $2.00/Share, For Total Of 500K Shares At An Aggregate Purchase Price Of ~$1M